Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022

Matthew Barth, Ana C. Xavier, Saro Armenian, Anthony N. Audino, Lindsay Blazin, David Bloom, Jong Chung, Kimberly Davies, Hilda Ding, James B. Ford, Paul J. Galardy, Rabi Hanna, Robert Hayashi, Cathy Lee-Miller, Andrea Judit Machnitz, Kelly W. Maloney, Lianna Marks, Paul L. Martin, David McCall, Martha PachecoAnne F. Reilly, Mikhail Roshal, Sophie Song, Joanna Weinstein, Sara Zarnegar-Lumley, Nicole McMillian, Ryan Schonfeld, Hema Sundar

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.

Original languageEnglish (US)
Pages (from-to)1267-1275
Number of pages9
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume20
Issue number11
DOIs
StatePublished - Nov 2022

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022'. Together they form a unique fingerprint.

Cite this